Sara Zeppilli first discovered neuroscience in her native Italy eight years ago. Now, she is a graduate student at Brown University and the first author of a study that lays the foundation for understanding the evolution of olfactory sensory processing across species.

An experimental drug for amyotrophic lateral sclerosis, or Lou Gehrig’s disease, slowed the neurological decline of volunteers in a closely watched clinical trial, according to researchers, offering a glimmer of hope for a patient population that desperately needs new treatment options.

Three Brown University students have received graduate awards for the 2020/2021 academic year from the Carney Institute for Brain Science.

A new study shines light on how information is channeled through an important relay station in the brain.

One of my favorite aspects of this program was the exposure to novel science. From journal clubs to the “Research in Progress” sessions, I constantly learned about interesting research projects.

Researchers with expertise in molecular sensors of neural activity and in the cells that myelinate axons will join the Carney Institute for Brain Science in January 2021.

In today’s episode, Christopher Moore, Professor of Neuroscience at Brown University, discusses his ideas for making scientific education more effective, shares the ways in which researchers regard new discoveries and new ideas, and offers Nick and his listeners great advice about how to chart their careers.

A team of researchers at Brown University’s Carney Institute for Brain Science has mapped the neural circuits that are key for forming memories of sensory cues associated with alcohol.

Brown University had just released its Virtual Degree Conferral program when graduating senior Logan Cho learned he received the inaugural Carney Institute for Brain Science Reproducible Paper Prize. The $750 award honors innovations in reproducibility of publications.

On the surface, amyotrophic lateral sclerosis (ALS) and Alzheimer's disease share two commonalities: Both are progressively debilitating neurodegenerative conditions--meaning symptoms get worse--and, at least for now, neither has an effective treatment, let alone a cure.

The following is a statement from the directors of the Carney Institute for Brain Science to members of the institute's community.

Deadly diseases don’t wait. Neither should good ideas. So when two undergraduates thought they’d found a way to stop neurodegeneration, they took action.

When Brown University transitioned to online learning in March due to the COVID-19 pandemic, graduate and undergraduate student teaching assistants grappled with transitioning the courses they supported, and their own studies, to a new learning environment.

If fearful emotions don’t encourage people to self-isolate, why did the fear message work?

By 2040, approximately one in five people in the U.S. will be 65 years old or older. As Americans are increasingly dealing with age-related diseases such as diabetes, heart disease, stroke, and Alzheimer’s, Brown researchers are trying to understand why aging occurs in an attempt to meet the country’s growing health care needs.

Scientists at the Carney Institute for Brain Science have identified one way that a synaptic calcium channel protein in sensory neurons is modulated, providing insight into mechanisms that contribute to chronic pain. The research has the potential to inform new therapeutic targets for abnormal pain conditions.